DocGo Inc.

DCGO Nasdaq CIK: 0001822359

Company Information

Industry Services-Health Services
SIC Code 8000
Entity Type operating
SEC Category Accelerated filer
State of Incorporation DE
Business Address 685 THIRD AVENUE, NEW YORK, NY, 10017
Mailing Address 685 THIRD AVENUE, NEW YORK, NY, 10017
Phone (844) 443-6246
Fiscal Year End 1231
EIN 852515483

Financial Overview

FY2024 FY

$624.29M
Revenue
$490.45M
Total Assets
$0.34
EPS

Recent SEC Filings

Form Type Date Filed Document
8-K Current report of material events January 30, 2026 View on SEC
4 Insider stock transaction report December 16, 2025 View on SEC
4 Insider stock transaction report December 16, 2025 View on SEC
4 Insider stock transaction report December 16, 2025 View on SEC
4 Insider stock transaction report December 16, 2025 View on SEC
4 Insider stock transaction report December 16, 2025 View on SEC
4 Insider stock transaction report December 16, 2025 View on SEC
4 Insider stock transaction report December 16, 2025 View on SEC
4 Insider stock transaction report December 16, 2025 View on SEC
8-K Current report of material events December 12, 2025 View on SEC

Material Events

8-K Financial Distress January 30, 2026
High Impact
  • DocGo Inc. (NASDAQ: DCGO) received a Nasdaq delisting warning for failing to meet the minimum $1.00 bid price requirement.
  • The stock's closing bid price remained below $1.00 for 30 consecutive business days, triggering the notice.
View Analysis

Insider Trading

SELL 1 insiders 1 recent transactions
View Full Insider Trading Profile

Related Companies

Companies in the same industry (SIC: 8000)

Investor Resources

Learn more about SEC filings and how to research public companies.

Important Disclaimer

This AI-generated analysis is for informational purposes only and does not constitute financial or investment advice. Always consult with qualified professionals and conduct your own research before making investment decisions.